Overview of ECHELON-1 Study for Hodgkin Lymphoma

  Dr. Anna Sureda, Head of the Onco-Hematology Service at Blood Cell Barcelona, gives an overview of the ECHELON-1 study of brentuximab vedotin as a frontline treatment for late-stage Hodgkin lymphoma. The trial finished in 2017. The primary objective of the...

Diagnostic Challenges of Thyroid Eye Disease

  Elizabeth Thompson, PhD at Horizon Therapeutics discusses the challenges of diagnosing thyroid eye disease (TED), a rare autoimmune disease causing permanent facial disfigurement severely affecting patients’ quality of life and daily function. The disease often...